General Information of Drug Off-Target (DOT) (ID: OTGYUFOJ)

DOT Name Constitutive coactivator of peroxisome proliferator-activated receptor gamma (FAM120B)
Synonyms Constitutive coactivator of PPAR-gamma; Constitutive coactivator of PPARG; PPARG constitutive coactivator 1; PGCC1; Protein FAM120B
Gene Name FAM120B
Related Disease
Fanconi anemia complementation group A ( )
Fanconi's anemia ( )
Visceral leishmaniasis ( )
UniProt ID
F120B_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MGVRGLQGFVGSTCPHICTVVNFKELAEHHRSKYPGCTPTIVVDAMCCLRYWYTPESWIC
GGQWREYFSALRDFVKTFTAAGIKLIFFFDGMVEQDKRDEWVKRRLKNNREISRIFHYIK
SHKEQPGRNMFFIPSGLAVFTRFALKTLGQETLCSLQEADYEVASYGLQHNCLGILGEDT
DYLIYDTCPYFSISELCLESLDTVMLCREKLCESLGLCVADLPLLACLLGNDIIPEGMFE
SFRYKCLSSYTSVKENFDKKGNIILAVSDHISKVLYLYQGEKKLEEILPLGPNKALFYKG
MASYLLPGQKSPWFFQKPKGVITLDKQVISTSSDAESREEVPMCSDAESRQEVPMCTGPE
SRREVPVYTDSEPRQEVPMCSDPEPRQEVPTCTGPESRREVPMCSDPEPRQEVPMCTGPE
ARQEVPMYTDSEPRQEVPMYTDSEPRQEVPMYTGSEPRQEVPMYTGPESRQEVPMYTGPE
SRQEVLIRTDPESRQEIMCTGHESKQEVPICTDPISKQEDSMCTHAEINQKLPVATDFEF
KLEALMCTNPEIKQEDPTNVGPEVKQQVTMVSDTEILKVARTHHVQAESYLVYNIMSSGE
IECSNTLEDELDQALPSQAFIYRPIRQRVYSLLLEDCQDVTSTCLAVKEWFVYPGNPLRH
PDLVRPLQMTIPGGTPSLKILWLNQEPEIQVRRLDTLLACFNLSSSREELQAVESPFQAL
CCLLIYLFVQVDTLCLEDLHAFIAQALCLQGKSTSQLVNLQPDYINPRAVQLGSLLVRGL
TTLVLVNSACGFPWKTSDFMPWNVFDGKLFHQKYLQSEKGYAVEVLLEQNRSRLTKFHNL
KAVVCKACMKENRRITGRAHWGSHHAGRWGRQGSSYHRTGSGYSRSSQGQPWRDQGPGSR
QYEHDQWRRY
Function Functions as a transactivator of PPARG and ESR1. Functions in adipogenesis through PPARG activation.
Tissue Specificity Widely expressed.
Reactome Pathway
Transcriptional regulation of white adipocyte differentiation (R-HSA-381340 )
PPARA activates gene expression (R-HSA-1989781 )

Molecular Interaction Atlas (MIA) of This DOT

3 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Fanconi anemia complementation group A DIS8PZLI Strong Genetic Variation [1]
Fanconi's anemia DISGW6Q8 Strong Genetic Variation [1]
Visceral leishmaniasis DISTKEYK Disputed Genetic Variation [2]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Constitutive coactivator of peroxisome proliferator-activated receptor gamma (FAM120B). [3]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Constitutive coactivator of peroxisome proliferator-activated receptor gamma (FAM120B). [7]
------------------------------------------------------------------------------------
6 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Constitutive coactivator of peroxisome proliferator-activated receptor gamma (FAM120B). [4]
Cisplatin DMRHGI9 Approved Cisplatin affects the expression of Constitutive coactivator of peroxisome proliferator-activated receptor gamma (FAM120B). [5]
Decitabine DMQL8XJ Approved Decitabine affects the expression of Constitutive coactivator of peroxisome proliferator-activated receptor gamma (FAM120B). [5]
Curcumin DMQPH29 Phase 3 Curcumin decreases the expression of Constitutive coactivator of peroxisome proliferator-activated receptor gamma (FAM120B). [6]
Trichostatin A DM9C8NX Investigative Trichostatin A increases the expression of Constitutive coactivator of peroxisome proliferator-activated receptor gamma (FAM120B). [8]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of Constitutive coactivator of peroxisome proliferator-activated receptor gamma (FAM120B). [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)

References

1 A senataxin-associated exonuclease SAN1 is required for resistance to DNA interstrand cross-links.Nat Commun. 2018 Jul 3;9(1):2592. doi: 10.1038/s41467-018-05008-8.
2 Genetic and functional evaluation of the role of DLL1 in susceptibility to visceral leishmaniasis in India.Infect Genet Evol. 2012 Aug;12(6):1195-201. doi: 10.1016/j.meegid.2012.04.017. Epub 2012 Apr 24.
3 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
4 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
5 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
6 Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB. Carcinogenesis. 2008 Apr;29(4):779-89.
7 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
8 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
9 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.